Literature DB >> 22294406

Overview of high-throughput screening.

Michael Entzeroth1, Horst Flotow, Peter Condron.   

Abstract

High-throughput screening (HTS) is a key process used in drug discovery to identify hits from compound libraries that may become leads for medicinal chemistry optimization. This updated overview discusses the utilization of compound libraries, compounds derived from combinatorial and parallel synthesis campaigns and natural product sources; creation of mother and daughter plates; and compound storage, handling, and bar coding in HTS. The unit also presents an overview of established and emerging assay technologies (i.e., time-resolved fluorescence, fluorescence polarization, fluorescence-correlation spectroscopy, functional whole cell assays, and high-content assays) and their integration in automation hardware and IT systems. This revised unit provides updated descriptions of state-of-the-art instrumentation and technologies in this rapidly changing environment. The section on assay methodologies now also covers enzyme complementation assays and methods for high-throughput screening of ion channel activities. Finally, a section on criteria for assay robustness is included discussing the Z'-factor, which is now a widely accepted criterion for evaluation and validation of high throughput screening assays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22294406     DOI: 10.1002/0471141755.ph0904s44

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  10 in total

1.  Class II biocompatible E-Shell 300 3D printing material causes severe developmental toxicity in Danio rerio embryos and reduced cell proliferation in vitro - implications for 3D printed microfluidics.

Authors:  Zuzana Nejedlá; David Poustka; Regina Herma; Michaela Liegertová; Marcel Štofik; Jiří Smejkal; Václav Šícha; Pavel Kaule; Jan Malý
Journal:  RSC Adv       Date:  2021-05-04       Impact factor: 4.036

2.  High content screening of a kinase-focused library reveals compounds broadly-active against dengue viruses.

Authors:  Deu John M Cruz; Andrea Cristine Koishi; Juliana Bosso Taniguchi; Xiaolan Li; Rafaela Milan Bonotto; Joo Hwan No; Keum Hyun Kim; Sungmin Baek; Hee Young Kim; Marc Peter Windisch; Ana Luiza Pamplona Mosimann; Luana de Borba; Michel Liuzzi; Michael Adsetts Edberg Hansen; Claudia Nunes Duarte dos Santos; Lucio Holanda Freitas-Junior
Journal:  PLoS Negl Trop Dis       Date:  2013-02-21

3.  OPERA models for predicting physicochemical properties and environmental fate endpoints.

Authors:  Kamel Mansouri; Chris M Grulke; Richard S Judson; Antony J Williams
Journal:  J Cheminform       Date:  2018-03-08       Impact factor: 5.514

Review 4.  Natural Products as Modulators of Sirtuins.

Authors:  Berin Karaman Mayack; Wolfgang Sippl; Fidele Ntie-Kang
Journal:  Molecules       Date:  2020-07-20       Impact factor: 4.411

5.  Using Docker Compose for the Simple Deployment of an Integrated Drug Target Screening Platform.

Authors:  Markus List
Journal:  J Integr Bioinform       Date:  2017-06-10

6.  High-throughput metabolomics predicts drug-target relationships for eukaryotic proteins.

Authors:  Duncan Holbrook-Smith; Stephan Durot; Uwe Sauer
Journal:  Mol Syst Biol       Date:  2022-02       Impact factor: 11.429

Review 7.  Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins.

Authors:  Lingxin Hou; Ying Zhang; Han Ju; Srinivasulu Cherukupalli; Ruifang Jia; Jian Zhang; Bing Huang; Arianna Loregian; Xinyong Liu; Peng Zhan
Journal:  Acta Pharm Sin B       Date:  2021-11-19       Impact factor: 14.903

8.  Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach.

Authors:  Natarajan Arul Murugan; Sanjiv Kumar; Jeyaraman Jeyakanthan; Vaibhav Srivastava
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

Review 9.  Chemical Screening of Nuclear Receptor Modulators.

Authors:  Mari Ishigami-Yuasa; Hiroyuki Kagechika
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

10.  IPA-3: An Inhibitor of Diadenylate Cyclase of Streptococcus suis with Potent Antimicrobial Activity.

Authors:  Haotian Li; Tingting Li; Wenjin Zou; Minghui Ni; Qiao Hu; Xiuxiu Qiu; Zhiming Yao; Jingyan Fan; Lu Li; Qi Huang; Rui Zhou
Journal:  Antibiotics (Basel)       Date:  2022-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.